Archive

ECCO 2016: Professor David Rubin from Chicago discusses the challenges of UC management and optimising biological therapy

Management of ulcerative colitis: putting patients at the centre – by Maria Dalby Iris Dotan (Tel Aviv Sourasky Medical Centre, Israel), Peter Irving (Guy’s and St Thomas’ NHS… read more.

UEGW 2015: Vaccination in IBD. An interview with Dr Herbert Tilg, Innsbruck Medical University, Austria. Conducted by Sanjay Tanday

UEGW 2015: Management of IBD after anti-TNF failure. Professor Laurent Peyrin-Biroulet (Nancy, France) discusses his presentation on when to use anti-integrins or anti-TNFs and the iCARE programme sponsored by ECCO.

by Maria Dalby: Managing patients with active disease who fail to respond to anti-TNF therapy remains a key unmet need in IBD. Introducing a free paper session on… read more.

IBD: What's new in 2015: Professor Laurent Peyrin-Biroulet (Nancy, France), Professor Prateek Sharma (Kansas, USA), Professor Brian Feagan (London, Canada) and Professor David Wilson (Edinburgh, UK) discuss their highlights of UEGW 2015. Conducted by Sanjay Tanday.

by Sanjay Tanday: Advances in diagnostics and therapy means the prospects of living a normal active life free of symptoms and disability are better than ever for IBD… read more.

IBD: What’s new in 2015: Professor Laurent Peyrin-Biroulet (Nancy, France), Professor Prateek Sharma (Kansas, USA), Professor Brian Feagan (London, Canada) and Professor David Wilson (Edinburgh, UK) discuss their highlights of UEGW 2015. Conducted by Sanjay Tanday.

by Sanjay Tanday: Advances in diagnostics and therapy means the prospects of living a normal active life free of symptoms and disability are better than ever for IBD… read more.

UEGW 2015: Complications of Crohn's disease

by Maria Dalby: Accurate diagnosis and monitoring are key elements in the prevention of long-term complications of Crohn’s disease including stenosis, strictures and perforation. Rising Star award winner… read more.

UEGW 2015: Complications of Crohn’s disease

by Maria Dalby: Accurate diagnosis and monitoring are key elements in the prevention of long-term complications of Crohn’s disease including stenosis, strictures and perforation. Rising Star award winner… read more.

Remsima®, a biosimilar infliximab, shows efficacy and safety in “real world” analysis

by Bruce Sylvester – New “real world” data suggests that the efficacy of Remsima® (infliximab),  a biosimilar monoclonal antibody (mAb) anti-TNF-alpha agent approved by the European Commission, is… read more.

Oxycodone/naloxone combination produces a stronger reduction of pain intensity and pain-related functional impairment vs. other opioids

Strong opioids including oxycodone are amongst the most effective analgesics to  combat  moderate  to  severe  pain  of  various  aetiologies,  but  opioid-induced  bowel  dysfunction  (OIBD) represents  a  relevant  problem. 

ITS 2012 Report – Nutrition and gut immunity – Are we eating the enemy?

by Maria Dalby – It is possible to modulate the body’s immune system by altering the gut microbiota, simply by changing the diet.